Bourbon-based Hand Sanitizer During Shortages Did It Work

In early 2020, as global supply chains collapsed under pandemic pressure, pharmacies emptied of alcohol-based hand sanitizers almost overnight. With WHO and CDC guidelines recommending solutions containing at least 60% ethanol (or 70% isopropyl alcohol) for reliable pathogen inactivation, consumers scrambled for alternatives. Among the most widely circulated home “hacks” was the use of high-proof bourbon—often labeled “hand sanitizer in a pinch” on social media, shared in viral TikTok clips, and even referenced in local news segments. But did it work? Not in any meaningful or safe way—and understanding why reveals critical lessons about antimicrobial chemistry, regulatory oversight, and the dangers of conflating beverage alcohol with medical-grade disinfectants.

This article dissects the bourbon-sanitizer phenomenon not as folklore, but as a case study in public health improvisation gone awry. Drawing on FDA guidance, peer-reviewed microbiology research, and real-world incident reports from poison control centers, we clarify what bourbon actually contains, how its composition fails against viruses and bacteria, and why well-intentioned substitutions can carry serious clinical consequences. More importantly, we offer evidence-based alternatives that *were* validated during the shortage—and practical strategies readers can still apply in future supply disruptions.

Why Bourbon Was Misinterpreted as a Viable Substitute

The misconception originated from a surface-level truth: bourbon is an ethanol-based spirit. Most standard bourbons are bottled at 40–50% alcohol by volume (ABV), with some barrel-proof expressions reaching 60–65% ABV. Since the CDC’s minimum threshold for effective hand sanitizer is 60% ethanol, it seemed plausible—especially when paired with added glycerin or aloe vera—to “boost” bourbon into compliance.

But ethanol concentration alone doesn’t determine efficacy. Three interdependent factors govern antimicrobial action: alcohol concentration, contact time, and formulation stability. Bourbon fails all three:

• Concentration variability: Even at 65% ABV, bourbon is diluted by water, congeners (flavor compounds like tannins, esters, and aldehydes), and trace sugars—all of which interfere with ethanol’s ability to denature proteins and disrupt lipid membranes in microbes.
• Lack of viscosity agents: Commercial sanitizers include humectants (e.g., glycerol, propylene glycol) and thickeners (e.g., carbomer) to ensure the solution remains on skin long enough—typically 20–30 seconds—for full microbial kill. Bourbon evaporates too rapidly, reducing effective contact time to under 5 seconds.
• No pH stabilization: Optimal ethanol activity occurs between pH 6.5–8.0. Bourbon typically ranges from pH 4.0–4.8 due to organic acids formed during aging—too acidic for consistent virucidal performance, especially against enveloped viruses like SARS-CoV-2.

A 2021 study published in American Journal of Infection Control tested 12 commercially available bourbons (including Maker’s Mark, Woodford Reserve, and Booker’s) against Escherichia coli and human coronavirus 229E. None achieved ≥99.9% reduction after 30 seconds of exposure—even the 63.5% ABV barrel-proof samples. By contrast, WHO-recommended 80% ethanol gel achieved >99.99% reduction in 15 seconds.

The Critical Gap: Ethanol Purity vs. Beverage Complexity

Medical-grade ethanol used in approved hand sanitizers is purified to ≥95% purity (USP grade), then diluted precisely with sterile water and stabilizing agents. Beverage ethanol undergoes no such refinement. During bourbon production, corn, rye, or barley mash ferments into low-alcohol “beer,” which is distilled and aged in charred oak barrels. This process introduces dozens of biologically active compounds—including vanillin, syringaldehyde, furfural, and lactones—that contribute to aroma and taste but have no antiseptic function. Some, like acetaldehyde (a known carcinogen), may even irritate skin or compromise barrier integrity—increasing susceptibility to infection.

Worse, bourbon contains residual fusel oils—higher alcohols such as isoamyl alcohol and propanol—formed during fermentation. These compounds reduce ethanol’s membrane-disrupting efficiency and increase dermal toxicity. A 2022 toxicology review in Clinical Toxicology documented 17 cases of chemical burns and contact dermatitis linked to repeated use of bourbon-based “sanitizers,” particularly among healthcare workers who applied it multiple times daily.

“Alcohol-based hand rubs must be formulated—not improvised. The presence of congeners, organic acids, and tannins in spirits actively inhibits ethanol’s virucidal kinetics. Calling bourbon ‘sanitizer’ is like calling vinegar ‘antibiotic’—technically containing an active ingredient, but functionally inert for the intended purpose.” — Dr. Lena Torres, Infectious Disease Pharmacist and WHO Hand Hygiene Guidelines Contributor

What Actually Worked During the Shortage: Validated Alternatives

While bourbon failed, other emergency measures were rigorously evaluated and endorsed. The FDA issued temporary guidance in March 2020 permitting compounding of WHO-recommended formulations using food-grade ethanol (≥95% ABV) when pharmaceutical-grade supplies were unavailable. Distilleries pivoted successfully—not with their finished bourbon, but with undiluted, unaged distillate.

The following approaches demonstrated real-world efficacy and safety during peak shortages:

A Real-World Case: How One Rural Clinic Avoided Reliance on Bourbon “Solutions”

In April 2020, the 8-bed Pine Ridge Community Health Center in rural Kentucky faced total sanitizer depletion. With no nearby pharmacy and a 90-minute ambulance response time, staff feared nosocomial transmission. Rather than adopt community-suggested bourbon mixes, clinic leadership contacted the University of Kentucky College of Pharmacy’s emergency response team.

Within 48 hours, they received validated WHO-formula kits—including pre-measured USP ethanol, glycerol, and hydrogen peroxide—alongside training on pH verification using litmus strips and viscosity testing with calibrated flow timers. Staff compounded batches twice weekly in a clean utility room, labeling each with batch number, date, and pH reading. Over 12 weeks, hand hygiene compliance remained at 94%, and zero healthcare-associated infections were reported—despite admitting 37 confirmed COVID-19 patients.

Crucially, the clinic also implemented a “hand hygiene triad”: alcohol-based rub at point-of-care, soap-and-water stations in every exam room, and patient education handouts emphasizing technique over product. As nurse manager Debra Hayes noted in her post-crisis report: “We didn’t need stronger alcohol—we needed smarter systems. Bourbon sounded clever until someone tried it on a diabetic patient’s cracked knuckles and triggered cellulitis.”

Step-by-Step: How to Evaluate Any “Emergency” Disinfectant Claim

When supply chain stress resurfaces—or new viral threats emerge—consumers and small facilities need a rapid, evidence-based filter for disinfectant claims. Follow this five-step assessment before adopting any non-commercial solution:

1. Verify ethanol concentration: Confirm the base alcohol is ≥95% ABV (190 proof) via Certificate of Analysis—not label claims. Most “grain alcohol” sold in stores is 95% USP; most “vodka” is 40% ABV.
2. Check for stabilizers: Effective gels require ≥1.4% glycerol (or equivalent humectant) to slow evaporation and ensure ≥20 sec contact time. Pure ethanol dries in under 8 seconds.
3. Test pH (if possible): Use narrow-range pH strips (6.0–8.0). Discard if reading is <6.2 or >7.8. Low pH impairs ethanol’s protein-denaturation capacity.
4. Assess skin tolerance: Apply a pea-sized amount to inner forearm. Wait 15 minutes. If redness, stinging, or tightness occurs, do not use on hands—especially if caring for immunocompromised individuals.
5. Confirm regulatory alignment: Cross-check with current FDA or WHO guidance. As of 2024, the FDA maintains its 2020 EUA list of authorized ethanol sources and explicitly warns against use of “beverage alcohols, including whiskey, rum, tequila, or wine” in hand hygiene products.

FAQ: Addressing Lingering Questions

Could adding glycerin and hydrogen peroxide to bourbon make it effective?

No. Glycerin improves viscosity but cannot overcome bourbon’s low ethanol purity, acidic pH, and congener load. Hydrogen peroxide degrades rapidly in acidic environments (like bourbon’s pH ~4.5), losing >90% of its oxidative power within 2 hours. The resulting mixture lacks reproducible antimicrobial activity and increases risk of chemical irritation.

Did any health authorities ever endorse bourbon-based sanitizer?

No major authority did. The CDC, WHO, FDA, and European Centre for Disease Prevention and Control all issued explicit warnings against using beverage alcohol. In May 2020, the FDA published a bulletin titled “Do Not Use Whiskey, Vodka, or Other Alcoholic Beverages as Hand Sanitizer,” citing “inadequate ethanol concentration, unknown impurities, and lack of efficacy data.”

What should I do if I already used bourbon as hand sanitizer?

If used once or twice without adverse reaction, no action is needed beyond switching to an approved product. If you experienced burning, rash, blistering, or persistent dryness, discontinue use immediately and consult a dermatologist. For accidental ingestion (especially by children), contact Poison Control at 1-800-222-1222—bourbon-based “sanitizers” pose significant ingestion risks due to higher ABV and unregulated additives.

Conclusion: Learning from the Shortage Without Repeating Its Mistakes

The bourbon-sanitizer episode wasn’t merely a footnote in pandemic history—it was a stress test of public scientific literacy, regulatory agility, and our collective tendency to seek simple answers to complex biological problems. It revealed how quickly misinformation spreads when fear outpaces evidence, and how easily “good enough” substitutes undermine real protection. Yet it also showcased resilience: distilleries retooling for public good, pharmacists compounding under emergency protocols, and communities prioritizing verified science over viral convenience.

Today, supply chains are more robust—but new threats emerge constantly. Climate-driven outbreaks, antimicrobial resistance, and geopolitical instability mean shortages won’t disappear. What matters isn’t whether we’ll face another crisis, but whether we’ll meet it with better tools, sharper judgment, and deeper respect for the science that separates ritual from reality.

Start now. Audit your current hand hygiene supplies. Bookmark the FDA’s Hand Sanitizer Resource Page. Share this analysis with a colleague who still keeps a mini-bottle of bourbon “just in case.” Because preparedness isn’t about stockpiling shortcuts—it’s about knowing which shortcuts actually lead somewhere safe.